Levothyroxine addendum.
D002170:Canada; D005252:Fees, Pharmaceutical / Q000639:trends; D006801:Humans; D017387:Investigational New Drug Application / Q000191:economics; D013974:Thyroxine; D014481:United States
D013974:Thyroxine